Loading market dashboard

Estimates, scoring, valuation assumptions, and peer comparison in one research surface.
Shield Therapeutics plc · Forecast overview
Bars show expected revenue while the line tracks expected EPS.
| Period | Revenue avg | Revenue range | EBITDA | EPS avg | Analysts |
|---|---|---|---|---|---|
| Dec 2029 | $127.11M | $113.54M - $143.73M | -$98.16M | $0.00 | 2 |
| Dec 2028 | $88.56M | $79.10M - $100.13M | -$68.39M | $0.009 | 3 |
| Dec 2027 | $77.64M | $67.50M - $93.01M | -$59.96M | $0.007 | 3 |
| Dec 2026 | $56.63M | $52.43M - $58.80M | -$43.73M | -$0.00 | 3 |
| Dec 2025 | $37.11M | $36.18M - $37.86M | -$28.66M | -$0.011 | 3 |
| Dec 2024 | $25.74M | $24.74M - $26.26M | -$144.08M | -$0.027 | 3 |
| Dec 2023 | $21.47M | $19.18M - $24.28M | -$16.58M | -$0.047 | 2 |
| Dec 2022 | $8.55M | $8.07M - $8.96M | -$71.23M | -$0.083 | 1 |
| Dec 2021 | $1.51M | $1.43M - $1.58M | -$32.15M | -$0.086 | 1 |
| Dec 2020 | $9.34M | $8.82M - $9.79M | -$38.23M | -$0.004 | 1 |
| Dec 2019 | $2.84M | $2.68M - $2.98M | -$369.7K | -$0.055 | 1 |
| Dec 2018 | $12.33M | $11.64M - $12.92M | -$328.20M | -$0.008 | 1 |